Picture of BioInvent International AB logo

BINV BioInvent International AB Income Statement

0.000.00%
se flag iconLast trade - 00:00
HealthcareAdventurousSmall CapSucker Stock

Annual income statement for BioInvent International AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

2017
December 31st
2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue4538.593.714719.4
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses146162232223298
Operating Profit-101-123-138-75.5-278
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes-101-123-139-76.3-278
Provision for Income Taxes
Net Income After Taxes-101-123-139-76.3-278
Net Income Before Extraordinary Items
Net Income-101-123-139-76.3-278
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-101-123-139-76.3-278
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-8.08-8.89-7.51-2.66-5.14
Dividends per Share

Or unlock with your email

Or unlock with your email